Horizon Therapeutics (HZNP) – Reuters
-
Amgen completes $27.8 billion Horizon Therapeutics deal
-
California, other states join FTC bid to block Amgen deal
-
FTC effort to stop Amgen's Horizon takeover faces uphill fight
-
Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears
-
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
-
FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source
-
U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals
-
Drugmakers raise 2018 U.S. prices, stick to self-imposed limits
-
Starboard urges Depomed board to pursue a potential sale
-
Valeant's looming M&A hiatus deals blow to investment banks
-
U.S. biotech bloodbath hits hedge funds but some bargains emerge
Back to HZNP Stock Lookup